Sana Biotechnology, Inc. financial data

Symbol
SANA on Nasdaq
Location
188 East Blaine Street, Suite 400, Seattle, WA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 356 % -22.5%
Debt-to-equity 114 % +37.6%
Return On Equity -115 % -61.1%
Return On Assets -54 % -37.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 238M shares +6.9%
Common Stock, Shares, Outstanding 231M shares +3.74%
Entity Public Float 596M USD -0.73%
Common Stock, Value, Issued 23K USD +4.55%
Weighted Average Number of Shares Outstanding, Basic 238M shares +1.69%
Weighted Average Number of Shares Outstanding, Diluted 238M shares +1.69%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 167M USD -32%
General and Administrative Expense 53.2M USD -26.9%
Operating Income (Loss) -258M USD -2.11%
Net Income (Loss) Attributable to Parent -252M USD -2.97%
Earnings Per Share, Basic -1 USD/shares +7.02%
Earnings Per Share, Diluted -1 USD/shares +7.02%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71.3M USD -47.2%
Marketable Securities, Current 1.4M USD -98.8%
Assets, Current 82.5M USD -68.7%
Property, Plant and Equipment, Net 33.1M USD -61.5%
Operating Lease, Right-of-Use Asset 43M USD -31.9%
Intangible Assets, Net (Excluding Goodwill) 59.2M USD 0%
Goodwill 141M USD 0%
Other Assets, Noncurrent 3.22M USD -49.1%
Assets 362M USD -41.5%
Accounts Payable, Current 2.27M USD -40.5%
Employee-related Liabilities, Current 9.41M USD -39.6%
Liabilities, Current 33.4M USD -34%
Operating Lease, Liability, Noncurrent 71.7M USD -19.1%
Other Liabilities, Noncurrent 8.24M USD +12.9%
Liabilities 239M USD -14.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.75B USD -16.9%
Stockholders' Equity Attributable to Parent 123M USD -63.9%
Liabilities and Equity 362M USD -41.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.7M USD +25.9%
Net Cash Provided by (Used in) Financing Activities 982K USD -99.5%
Net Cash Provided by (Used in) Investing Activities 16.6M USD
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 231M shares +3.74%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.1M USD -171%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 75.5M USD -45.6%
Deferred Tax Assets, Valuation Allowance 451M USD +11.9%
Deferred Tax Assets, Gross 465M USD +9.45%
Operating Lease, Liability 85.5M USD -13.3%
Depreciation 16.3M USD -30.5%
Payments to Acquire Property, Plant, and Equipment 136K USD -99.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -252M USD -3.32%
Lessee, Operating Lease, Liability, to be Paid 130M USD -28.3%
Property, Plant and Equipment, Gross 85.7M USD -36.6%
Operating Lease, Liability, Current 13.8M USD +38.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.4M USD -13.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.5M USD +3.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure -8.77%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 44.8M USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14.7M USD -26.1%
Deferred Tax Assets, Operating Loss Carryforwards 228M USD +18.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.1M USD -7.59%
Additional Paid in Capital 1.87B USD +1.91%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 14.7M USD -34.8%
Share-based Payment Arrangement, Expense 30.9M USD -17.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%